Direxion Daily CSI China Internet Bull 2X Shares vs Zoetis Inc — how do they compare? Direxion Daily CSI China Internet Bull 2X Shares trades at $18.23 (market cap $176.60M), while Zoetis Inc trades at $73.02 (market cap $29.57B). The key difference: Zoetis Inc is far larger — about 167.4× Direxion Daily CSI China Internet Bull 2X Shares's market cap, and Zoetis Inc pays a 2.96% dividend while Direxion Daily CSI China Internet Bull 2X Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Direxion Daily CSI China Internet Bull 2X Shares for 24 Days and Zoetis Inc for 70 Days on average.
| CWEB | ZTS | |
|---|---|---|
Market Cap | $176.60M | $29.57B |
Volume | 440,349 | 4,128,093 |
Sector | Leveraged / Inverse | Health |
52-Week High | $55.62 | $147.53 |
52-Week Low | $17.39 | $69.09 |
Typical Hold Time | 24 Days | 70 Days |
Enterprise Value | — | $37.13B |
Dividend Yield | — | 2.96% |
Signals from Pluang's Aura AI — not financial advice
CWEB trades at $18.02, down 1.85% today amid bearish technical signals. The stock shows weak momentum with all 13 moving averages signaling sell, though oscillators are neutral. Recent news highlights China's AI ambitions and potential for China growth stocks to surge, providing thematic catalysts. Financial ratios remain undisclosed in current data.
Outlook hinges on China's tech sector recovery and AI growth narrative. Risks include geopolitical tensions and market volatility. The upcoming dividend of $0.07 in September 2026 offers income potential, but investors need clarity on fundamentals for sustained upside.
Zoetis (ZTS) trades at $73.08, up 2.47% on the day, but remains in a bearish technical trend with support near $70. Fundamentally, the company reported strong 2025 results with $9.47B revenue, $2.67B net income, and robust margins, though recent quarters show mixed earnings performance. Analyst consensus is a Buy with a $87.33 price target, but sentiment is cautious due to U.S. pet care weakness and competitive pressures.
The stock offers value with a P/E of 11.67 and a 3% dividend yield, but near-term headwinds include declining U.S. companion animal sales and margin compression. Long-term growth prospects remain intact given industry leadership and international resilience, making it a contrarian opportunity for patient investors despite technical and competitive risks.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
CWEB is a leveraged ETF that seeks to provide two times (2x) the daily performance of the CSI China Internet Index. It offers magnified exposure to top Chinese internet companies listed on US and Hong Kong exchanges.
Read more on CWEB →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →